Temporary hair loss is a commonly known side effect of many cancer treatments. Many women who undergo chemotherapy treatment expect this and are told by their doctors that their hair will grow back after chemotherapy treatments end. However, for many women who were treated with the chemotherapy drug Taxotere, this wasn’t the case.
More than 33 Taxotere hair loss lawsuits are pending across the United States after women treated with this drug experienced permanent hair loss without being warned of the potential side effect. If you are among the patients affected by this treatment, the Taxotere lawyers at The Lambert Firm can help you pursue legal action.
The chemotherapy drug Taxotere (docetaxel) is FDA approved to treat breast cancer, advanced stomach cancer, non-small cell lung cancer, metastatic prostate cancer, and head and neck cancer. This drug is from a family of medications called taxanes and is administered intravenously with the goal of preventing cancer cells from dividing and growing.
Taxotere has many side effects, including:
- Pain in the bones, muscles and joints
- Constipation or diarrhea
- Fluid retention
- Mouth sores
- Numbness in fingers and toes
- Low white cell count
In Canada and Europe, this chemotherapy treatment also carried a warning that permanent alopecia (hair loss) is a side effect. These warnings were not included in the U.S. until 2015. Lawsuits filed against Sanofi-Aventis, the maker of Taxotere, state that the manufacturer failed to warn doctors and patients of the increased risk of permanent hair loss.
These lawsuits point out that there are other chemotherapy drugs that patients could have chosen that are more effective and do not result in permanent alopecia had the manufacturer given adequate warnings about the Taxotere side effects.
Damages Of Permanent Alopecia
Alopecia, the medical term for hair loss, can potentially occur with any chemotherapy or radiation therapy treatment. Hair may fall out gradually, only in certain sections, or completely. For some patients, their hair becomes thinner and dryer but does not completely fall out. This condition is usually temporary, and the hair regrows after treatment is completed.
However, permanent hair loss among patients treated with Taxotere has many damaging effects. Women in particular report lower self-esteem and self-confidence, depression, and other emotional and psychological effects from the loss of hair. These feelings are made far worse when the condition is permanent and the patient was not warned that this could happen.
Sanofi had a moral obligation and a legal duty to adequately inform medical practitioners and patients of the risks involved in Taxotere treatment. Failure in that duty is grounds for legal action.
Get Help From Taxotere Lawyers
The Taxotere lawyers at The Lambert Firm are currently reviewing potential mass torts claims against Sanofi-Aventis. If you experienced permanent alopecia as a result of treatment with this drug, contact us today to learn more about a potential Taxotere hair loss lawsuit and how we can help you.